In the meantime, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) didn't do well in the courts: Teva, along with Sun Pharmaceutical, will pay Pfizer Inc. (NYSE:PFE) approximately $2.1 billion for settling a patent suit. Teva lost in a recent lawsuit in which it sued Mylan for infringing its patents for treating multiple sclerosis. These lost lawsuits and settlements are likely to adversely affect the company's financials.